Philogen SpA (STU:78Q) Beginning Cash Position : €12.26 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Beginning Cash Position?

Philogen SpA's Beginning Cash Position for the quarter that ended in Dec. 2024 was €12.26 Mil.

Philogen SpA's quarterly Beginning Cash Position declined from Dec. 2023 (€36.59 Mil) to Jun. 2024 (€15.64 Mil) and declined from Jun. 2024 (€15.64 Mil) to Dec. 2024 (€12.26 Mil).

Philogen SpA's annual Beginning Cash Position increased from Dec. 2022 (€8.88 Mil) to Dec. 2023 (€24.44 Mil) but then declined from Dec. 2023 (€24.44 Mil) to Dec. 2024 (€15.64 Mil).

Philogen SpA Beginning Cash Position Historical Data

The historical data trend for Philogen SpA's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Beginning Cash Position Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

3.57

12.52

8.88

24.44

15.64

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial					11.47	24.44	36.59	15.64	12.26

Philogen SpA Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Philogen SpA Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

PHIL:Italy 78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines